Growth through healthcare SAH Global is actively pursuing world-class proton therapy centers in the MENA region, presenting a clear opportunity to pitch medical equipment, facility construction, IT infrastructure, and healthcare training solutions tailored to oncology programs.

Advanced therapy focus The company has shown interest in cutting-edge cancer treatments such as Boron Neutron Capture Therapy (BNCT), indicating openness to specialized devices, clinical collaboration platforms, and research partnerships that require novel treatment delivery systems and associated software.

Regional expansion SAH Global aims to build a network of regional centers with international scope, suggesting opportunities for scalable managed services, facility automation, cybersecurity, digital patient management, and global supply chain solutions.

Strategic leadership Led by founder Feroz Agad with a track record of profitability, SAH Global represents a partner with growth velocity and project-management discipline, suitable for co-investment models, strategic alliances, and long-cycle procurement engagements.

Recognition and revenue With revenue in the lower mid-range and a recent Top 50 Healthcare Company accolade, there is potential to upsell enterprise IT, analytics, and healthcare revenue cycle management solutions as the company scales its operations and expands its portfolio.